Screening for Chronic Kidney Disease: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2012;157:I-50. doi: 10.7326/0003-4819-157-8-201210160-00534
Download citation file:
Published: Ann Intern Med. 2012;157(8):I-50.
The U.S. Preventive Services Task Force (USPSTF) is a group of health experts that makes recommendations about preventive health care.
The kidneys remove waste and water from the blood. In chronic kidney disease (CKD), kidney function may worsen over time. In a small number of people with CKD, the kidneys will stop working. When the kidneys stop working, dialysis is needed to filter the blood using machines. Caring for CKD involves controlling diet and blood pressure and taking medications to delay heart complications and the need for dialysis. Many patients do not know that they have CKD and do not receive care to delay complications.
Glomerular filtration rate is a measure of kidney function and can be estimated using equations that are based on the measurement of levels of creatinine, a substance in the blood. It is also possible to look for CKD by measuring urinary levels of a substance called albumin. Chronic kidney disease is most common in people with high blood pressure or diabetes, and people with these conditions should talk to their doctors about being periodically tested for CKD. However, CKD can occur in apparently healthy people who do not have high blood pressure or diabetes. For this reason, the USPSTF aimed to determine whether routine screening of healthy adults for CKD would improve patient outcomes.
The USPSTF reviewed research about the potential accuracy, benefits, and harms of screening for CKD. It also reviewed research about the benefits and harms of early versus later treatment of CKD.
The USPSTF found that studies are lacking to show whether screening healthy adults for CKD improves outcomes. Although there are no direct studies of the harms of screening, the medications used to treat early CKD can have side effects.
The USPSTF concluded that there is not enough evidence to recommend either for or against screening healthy people for CKD.
Patients who have diabetes, high blood pressure, or bad cholesterol levels should generally be treated for these conditions regardless of whether they also have CKD.
These recommendations do not apply to people with diabetes, high blood pressure, or symptoms that could be caused by CKD.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Nephrology, Chronic Kidney Disease, Prevention/Screening.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only